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Conclusions: Exogenous Pim-3 gene can protect rats from LPS/D-
GalN-induced fulminant hepatic failure.
PP-032 Hepatoprotective activity of Momordica
cymbalaria Hook. F against thioacetamide
induced hepatic injury in rats
B.M. Vrushabendra Swamy*,1, K.N. Jayaveera2,
Kumar Prashanth1, K.S. Nataraj3. 1Srinivasa Institute of
Pharmaceutical Sciences, Sri Chowdeswari Nagar,
Peddasettipally, Proddatur, Kadapa (Dist), A.P, India; 2Oil
Technology Research Institute, Jawaharlal Nehru Technological
University, Anantapur, A.P, India; 3SRR College of Pharmacy,
Valbhapur, Elkathurti, Kareem Nagar (Dist), A.P, India
Objective: The study was aimed at assessing the in vivo antioxi-
dant and hepatoprotective activity of methanol extract of fruits
of Momordica cymabalaria Hook. F. (MEMC) against thiacetamide
(100 mg/kg, sc) induced hepatic damage in albino rats.
Methods: The in vivo antioxidant activity was determined by
estimating the tissue levels of GSH and lipid peroxidation. The
degree of hepatoprotection was assessed by estimating levels
of biochemical markers like SGPT, SGOT, ALP, bilirubin (total
and direct), cholesterol and HDL. 200, 400 and 600mg/kg were
used to assess the protective property in thioacetamide model of
hepatotoxicity in rats.
Results: The MEMC produced signiﬁcant effect by decreasing the
activity or level of serum enzymes, bilirubin, cholesterol, HDL
and tissue lipid peroxidation, while it signiﬁcantly increased the
levels of tissue GSH in a dose dependent manner. The effects of
extract were compared with standard, silymarin at 100 mg/kg
dose.
Conclusion: These results suggested that methanolic extract of
Momordica cymabalaria fruits possess hepatoprotective activity
against thioacetamide induced hepatic damage and signiﬁcant
antioxidant activity in rats.
PP-033 Preparation and identiﬁcation of anti-HCMV gBn1
antibody
Jun Fan*, Xuan Zhang, Xiaoming Chen, Hainv Gao, Meifang Yang,
Hong Zhao, Jianhua Hu, Weihang Ma. State Key Laboratory for
Diagnosis and Treatment of Infectious Diseases, First Afﬁliated
Hospital, Zhejiang University School of Medicine, Hangzhou,
China
Background: Envelope glycoprotein B (gB) of HCMV plays an
important role in human cytomegalovirus (HCMV) infection. gBn1
holds an obvious quantitative advantage in HCMV infected Chi-
nese.
Methods: Based on the GenBank sequence (M60929), gBn1 anti-
gen peptide was synthesized. After the gBn1 peptide conjugated
Keyhole Limpet Hemocyanin immunized rabbits (including the
initial vaccination and three times of enhanced immunization),
rabbit antiserum were obtained, then puriﬁed by afﬁnity pu-
riﬁcation. ELISA, western-blot and immunoﬂuorescence methods
were used to detect speciﬁcity and sensitivity of the anti-
serum.
Result: Through ELISA, it showed that the antiserum could act
with gBn1 peptide, titer could reach 1:64000, and the antiserum
could response to the Towne strain,AD169 strain and gBn3 clinical
isolate strain. Immunoﬂuorescence methods showed that the an-
tiserum could act with HCMV Towne and AD169 strain. The lysate
of HCMV Towne strain, AD169 strain and MRC-5 were as antigen,
gBn1 peptide also as antigen,which acted to the antiserum in
Western blot analysis. It showed that the serum and Towne stain,
AD169 strain, gBn1 peptide appeared a clear band in molecular
weight of about 110KD, which was the same as the molecular
weight of HCMV gB; no other bands appeared.
Conclusion: By ELISA, immunoﬂuorescence and Western-blot,
the antiserum was able to sensitively and speciﬁcly identify
HCMV gBn1 peptide. Meanwhile, the antiserum could act with
HCMV Towne stain, AD169 stain. It indicated that gBn1 peptide
may include epitope. The research on the gBn1 peptide should
be carried on, which may help ﬁnding the key of HCMV immune
mechanism.
PP-034 Protection effect of TanshinoneIIA against
damage in cultured hepatocyte and inhibitory
action of TanshinoneIIA against actived hepatic
stellate cell
Lixin Liu*,1,2, Xiaohong Guo1, Haiyan Zhang1, Qianqian Zhang1.
1The First Hospital of Shanxi Medical University; 2The Institute
of Liver Disease of Shanxi Medical University
Background: To explore the safe dose range of TanshinoneIIA
in hepatocyte and investigate protective effect of TanshinoneIIA
on Tumor necrosis factor α (TNFα) or H2O2 damage cell models,
and search for inhibitory effect of TanshinoneIIA upon activated
hepatic stellate cell.
Methods: Human hepatocyte line HL-7702 was cultured in vitro
and treated with different concentrations of TanshinoneIIA, then
cell survival of hepatocyte was detected by MTT assay and super-
nate ALT and LDH were observed. Establishing hepatocyte models
induced TNFα and H2O2, supernate ALT and LDH were observed
and cell survival of hepatocyte was detected by MTT assay. Rat
HSC-T6 was cultured in vitro and treated with different concen-
trations of TanshinoneIIA, cell survival of HSC was detected by
MTT assay.
Result: 1. TanshinoneIIA has no cytotoxicity to hepatocyte in a
certain dose range. Cell survival of hepatocyte decreased and
the results of supernate ALT, LDH increased when exceeding the
certain dose. 2. TanshinoneIIA can improve the descent of cell
survival of hepatocyte and the increasing of supernate ALT, LDH
induced TNFα. 3. TanshinoneIIA can improve the descent of cell
survival of hepatocyte induced H2O2. 4. Activated HSC could be
inhibited by TanshinoneIIA.
Conclusion: 1. The safe dose range of TanshinoneIIA in cultured
HL-7702 is 1-2 mg/L. 2. The damage induced TNFα (20μg/L)
and H2O2 (7.5-15mmol/L) could be improved by TanshinoneIIA
in the safe dose range. 3. Activated HSC could be inhibited by
TanshinoneIIA in 25-100μg/ml.
PP-035 The protective effect and mechanism of
anti-IGFBP-rP1 antibody in the liver tissue of
mice with hepatic ﬁbrosis induced thioacetamide
Lixin Liu*,1,2, Qianqian Zhang1, Haiyan Zhang1, Junjun Xu1.
1The First Hospital of Shanxi Medical University; 2The Institute
of Liver Disease of Shanxi Medical University
Background: To investigate effects of anti-IGFBP-rP1 in mice
with hepatic ﬁbrosis induced thioacetamide (TAA), and explore if
mechanism is relate to TGF-β1/Smad3 signal path.
Methods: Thirty male Kunming mice were randomly divided into
ﬁve groups, including control group (A); TAA-four-week adding
anti-IGFBP-rP1 treated one week group (B) and TAA-four-week
group (C); TAA-ﬁve-week adding anti-IGFBP-rP1 treated one week
group (D) and TAA-ﬁve-week group (E). Hepatic tissues were
examined expressions of α-SMA, Collagen I, ﬁbronectin (FN),
TGF-β1 and Smad3 with both immuohistochemistry and Western
blot. The apoptosis of hepatic cells was detected by TUNEL.
Result: Contents of both ALT and LDH was signiﬁcantly increased
in C and E. It was signiﬁcantly decreased in B compared with that
of C; also in D compared with in E. Changes of α-SMA, Collagen
I, FN, TGF-β1 and Smad3 in hepatic tissues were signiﬁcantly in-
creased in C and E. It was signiﬁcantly decreased in B compared
with in C; also in decreased in D compared with in E. Expressions
of Smad3 have positive correlation with α-SMA, Collagen I, FN,
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TGF-β1 in each group. The apoptotic rate of hepatic cells in B
was signiﬁcantly reduced than that of C.
Conclusion: Anti-IGFBP-rP1 can prevent the progression of hep-
atic ﬁbrosis through inhibiting activation of HSC, reducing the
expressions of Collagen I and FN, reducing hepatocyte apop-
tosis and so on. The possible mechanism may relate to the
TGF-β1/Smad3 signal path.
PP-036 Dynamic changes of both IGFBPrP1 and
transforming growth factorβ1/Smad on liver
tissue with ﬁbrosis in mice
Lixin Liu*,1,2, Qianqian Zhang1, Haiyan Zhang1, Yongqiang Shi 1.
1The First Hospital of Shanxi Medical University; 2The Institute
of Liver Disease of Shanxi Medical University
Background: To investigate dynamic expressions of IGFBPrP1,
TGF β1 and Smad3 of mice with thioacetamide (TAA) - induced
hepatic ﬁbrosis.
Methods: Liver ﬁbrosis model of mice was made by intraperi-
toneal injecting with 5% TAA, 200mg/kg, three times per week,
totally for 4 or 5 or 6 weeks. Collagen accumulation in liver tis-
sues was detected by Masson staining. Distribution and dynamic
expressions of IGFBPrP1, α-SMA, Collagen I, FN, TGFβ1, Smad3
were detected by immunohistochemistry staining. Meanwhile,
expressions of IGFBPrP1, α-SMA, FN and Smad3 were examined
by Western Blot.
Result: During the progression of hepatic ﬁbrosis, expressions of
Collagen, IGFBPrP1, α-SMA, Collagen I, FN, TGFβ1, Smad3 were
gradually increased.Correlation analysis of immunohistochemi-
cal staining: during liver ﬁbrosis developing phases, IGFBPrP1
was signiﬁcantly positively correlated withα-SMA, Collagen I,
FN, TGFβ1, Smad3. The results of Western Blot analysis: Molec-
ular weight of β-actin, IGFBPrP1, α-SMA, FN, Smad3were 43,
31, 45, 220 and 58kD. The contents of IGFBPrP1, α-SMA, FN,
Smad3 were signiﬁcantly increased in model group compared
with control group, which were gradually increased with pro-
cess of ﬁbrosis. There was a signiﬁcant difference among model
group. Correlation analysis of Western Blot analysis: There was a
positive correlation between the expression of IGFBPrP1and the
expression of α-SMA, FN, Smad3.
Conclusion: IGFBPrP1 was involved in the formation and de-
velopment of hepatic ﬁbrosis; Meanwhile, this function of IGF-
BPrP1 probably relates to promote activation of HSC; promote
the synthesis and secretion of both collagenI and FN; affect
TGFβ1/Smad3 pathway.
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PP-037 Screening of speciﬁc serum biomarker of
anklosing spondylitis from a random peptide
library
Min Wang*, Xianping Li. Department of Clinical Laboratory, The
Second Xiangya Hospital of Central South University
Objective: To screen the speciﬁc serum biomarker of anklosing
spondylitis using peptide library biopanning technique.
Methods: Phage random peptide library of 12 amino acids was im-
munoscreenedwith puriﬁed IgG from sera of anklosing spondylitis
(AS) patients. Positive clones which were obtained after 3 rounds
of biopanning were detected by ELISA and 7 of them were se-
quenced. The binding test of positive clones with the AS patients,
systemic lupus erythematosus (SLE) patients, rheumatoid arthri-
tis (RA) patients, Osteoarthritis (OA) patients as well as healthy
controls were detected using phage-ELISA. The correlation anal-
yses were evaluated among the absorbance and erythrocyte
sedimentation rate (ESR) and C- reactive protein (CRP).
Result: After 3 rounds of screening, the radio of output to input
increase to 1.9×10-5. At the 3rd round of screening, 20 clones
were selected and 17 were proved to speciﬁcally react with the
sera of AS patients. The 7 clones sequenced were come from
the same one named AS1. Its inserted sequence was deduced to
be QSQRRARSIMMM. The positive rate of AS1 in diagnosis AS pa-
tients, SLE patients, RA patients, OA patients and healthy control
group was 92.0%, 56.7%, 50.0%, 13.3% and 14.0% respectively,
and there was signiﬁcant difference (χ2=77.418, P< 0. 01). The
absorbance values showed positive correlation with ESR and CRP,
the correlation coefﬁcients were 0.165 and 0.239.
Conclusion: These ﬁnding indicated that the short peptide QSQR-
RARSIMMM could be the speciﬁc serum biomarker of AS and may
be used in laboratory test.
PP-038 Dynamic expression of hypoxia inducible
factor-1α during the development of
hepatocellular carcinoma and its clinical values
Liwei Qiu*, Jing Qian, Dengfu Yao. Research Center of Clinical
Medicine, Afﬁliated Hospital of Nantong University, Nantong,
China
Objective: To investigate the dynamic expression and alter-
ation of hypoxia inducible factor-1α (HIF-1α) and its pathological
features in hepotacellular carcinoma (HCC).
Methods: Hepatomas model was induced with 2-FAA on male SD
rats for investigating dynamic changes of HIF-1α. Liver specimen
from HCC patients were collected by self-control method. The
expression, cellular distribution, and pathological features of
HIF-1αwere analyzed by immohistochemistry.
Results: Rat hepatocytes from granule-like degeneration to
atypical hyperplasia and HCC development, and the progressing
increasing of the levels of hepatic HIF-1α and HIF-1α mRNA
expression during the course. The levels of HIF-1α in hepatoma
tissues and sera were signiﬁcantly higher than those in normal
and degeneration ones. There was positive relationship of HIF-1α
levels between them in hepatoma tissues and sera (P<0.05). The
positive HIF-1αw as brown and granule-like, mainly presented in
cytoplasm and few in nucleus. The incidence was 80% (28/35) in
HCC, and 100% (35/35) in its surrounding tissues (P<0.001), re-
spectively. The clinical pathological features of HIF-1α expression
demonstrated that it correlated with tumor size, and its intensity
was negative correlated with the differentiation of HCC. No cor-
relation was found between HIF-1αand tumor numbers or serum
AFP level or positive-HBsAg.
Conclusions: Hepatic HIF-1α overexpression are associated with
development and prognosis of HCC.
PP-039 Determine the new serotype 6C Streptococcus
pneumoniae by serological method
Zunjie Liu*, Kaihu Yao, Lin Yuan, Wei Gao, Sangjie Yu,
Yonghong Yang. Beijing Pediatric Research Institute, Beijing
Children’s Hospital afﬂiated to Capital Medical University
Objective: To prepare serotype 6C diagnostic Streptococcus
pneumoniae antiserum, to determine it was a new serotype.
Methods: Serotype 6C was determined in USA by using multibean
assay.Immunizing rabbits with serotype 6C pneumococcal strains
for 0ne month. Detected the capsular titres of antiserumwith 6A,
6B and 6C before absorbed and latter by cross-reaction strains.
Results: None capsular reactions were detected from the an-
Table 1. Capsular titers of serotype 6C rabbit antisera to type 6A, 6B and 6C
Antisera 1× 2× 4× 8× 16× 32× 64× 128×
6A + + + + + + + –
6B + + + + + + – –
6C + + + + + + + –
